← Back to patent-cliff list
盐酸美金刚/盐酸多奈哌齐
Tier C — Watch / tradeMemantine Hydrochloride/Donepezil Hydrochloride
艾尔建
Originator
2014
First approval
-
Expiry (public)
$0.13B ▲
Peak sales
化学药
Type
Targets：NMDAR、AChE
Brand：Arimenda、Namzaric
Indications (approved)：阿尔茨海默病
Regional status
US
批准上市
2014-12-23
EU
终止
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Memantine Hydrochloride/Donepezil Hydrochloride?
Approved indications include: 阿尔茨海默病.
When does the Memantine Hydrochloride/Donepezil Hydrochloride patent expire?
No public expiry year is available for Memantine Hydrochloride/Donepezil Hydrochloride yet; this page updates once verified.
How do I get a quote for Memantine Hydrochloride/Donepezil Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24